Bennett C, Rivers EJ, Woo W, Bloch M, et al. Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial. J Infect Dis 2023 Nov 16:jiad508. doi: 10.1093.
PMID: 37970668